Sign inJoin waitlistJoin the waitlist

MR

Mark Robson

Chief, Breast Medicine Service · New York Presbyterian Hospital

Credentials: · · · · ·

History

Breast Medicine Service Division · New York Presbyterian Hospital
Present
New York Presbyterian Hospital
Present

Medical Oncology
1989–1991
Internal Medicine
Walter Reed National Military Medical Center
1986–1989
University of Virginia School of Medicine
1982–1986

Research

Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
Nature Medicine · 2017 · 2,750 citations
Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation
New England Journal of Medicine · 2017 · First of 14 authors · 2,618 citations
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
The Lancet · 2010 · 1,426 citations

KO
Kenneth Offit
186 papers
Susan Domchek
94 papers
ZS
Zsofia Stadler
79 papers · 11 as a fellow
Judy Garber
57 papers
Katherine Nathanson
50 papers
LN
Larry Norton
47 papers
DM
Diana Mandelker
45 papers · 3 as a fellow
Jeffrey Weitzel
44 papers
Nadine Tung
39 papers
Liying Zhang
38 papers · 25 as a resident
ML
Marc Ladanyi
38 papers
MW
Michael Walsh
37 papers

Clinical trials

Prospective Registry of Multiplex Testing (PROMPT)
Principal investigator · Active not recruiting
Memorial Sloan Kettering Cancer Center
2016–2027
Assessment of the Efficacy and Safety of Olaparib Monotherapy Versus Physicians Choice Chemotherapy in the Treatment of Metastatic Breast Cancer Patients With Germline BRCA1/2 Mutations.
Principal investigator · Completed · Phase 3
AstraZeneca
2014–2025
Multiplex Testing for Breast Cancer Susceptibility: A Pilot Study of Subject Preferences for Information and Responses After Testing
Principal investigator · Completed
Memorial Sloan Kettering Cancer Center
2013–2017
A Safety Study Assessing the Effects of Receiving Genome Sequencing Results
Principal investigator · Completed
Memorial Sloan Kettering Cancer Center
2012–2018